Earlier in March 2026, Vertex Pharmaceuticals reported positive pre-specified Week 36 interim Phase 3 RAINIER data for ...
VOYXACT is the first and only FDA-approved treatment for adults with primary IgAN at risk for disease progression that selectively inhibits A PRoliferation Inducing Ligand (APRIL), a key immune driver ...
Balkan endemic nephropathy (BEN) is a chronic tubulointerstitial disease described only in some rural parts of southeastern Europe. One of its most peculiar characteristics is a strong association ...
IgA nephropathy is believed to be caused by IgA1-containing immune complexes formed in the blood that ultimately deposit in the glomeruli — the filtering apparatus of the kidneys. When kidney ...
WITH THE INCREASING USE OF CONTRAST MEDIA in diagnostic and interventional procedures, nephropathy induced by contrast media has become the third leading cause of hospital-acquired acute renal failure ...
This page lists all known medications that could potentially lead to 'Nephropathy' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...
Diabetic nephropathy is kidney disease and it’s serious, but you can get screening tests to help diagnose this diabetes complication early enough to treat it. Diabetes-related nephropathy, also ...
Human immunodeficiency virus type 1 (HIV-1)–associated nephropathy is the chief cause of chronic renal disease in patients with HIV-1 infection and is now the third leading cause of end-stage renal ...
The FDA granted accelerated approval to sparsentan (Filspari) for proteinuria in IgA nephropathy, Travere Therapeutics announced, marking the first non-immunosuppressive therapy for this rare ...
The campaign features newly published research from Board members living with IgAN, alongside new educational resources ...
David Ozeri, MD, FACP, FACR, is a rheumatologist and current researcher at Sheba Medical Center in Israel. He worked at Kings County Hospital Center and treated veterans at New York Harbor Healthcare ...